A Phase I Trial of Humanized Monoclonal Antibody A33 in Patients With Colorectal Carcinoma: Biodistribution, Pharmacokinetics, and Quantitative Tumor Uptake
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-04-2329
Full Text
Open PDFAbstract
Available in full text
Date
July 1, 2005
Authors
Publisher
American Association for Cancer Research (AACR)